Sutro Biopharma, Inc 10-K for FY2023
Sutro Biopharma, Inc. (STRO)
10-K
2024-03-25
For: 2023-12-31
View Original
Added on
April 11, 2026
About this 10-K
Sutro Biopharma, Inc filed this 10-K on March 25, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $153.73M
- up 126.8% from $67.77M a year earlier
- Net loss
- $106.79M
- compared with a net loss of $119.2M a year earlier
- Diluted EPS
- -$1.78
- compared with -$2.35 a year earlier